Hans Biomedical (한스바이오메드)
KOSDAQ · KRX: 042520
Hans Biomedical is a South Korean medical device company listed on the KOSDAQ that develops and manufactures healthcare products, with a focus on diagnostic and therapeutic devices. The company serves both domestic and international markets through its portfolio of medical solutions in areas such as cardiovascular and other medical specialties.
Filing timeline
criticalspotted 15:36 KST
Hans Biomedical (KRX: 042520)- Osstem Implant filed a simplified large shareholding report (약식) on 2025-04-04 disclosing ownership of 1,415,354 shares, equal to 12.48% of Hans Biomedical (KRX: 042520, KOSDAQ).
- The reported stake increased by 58,373 shares (+0.44 percentage points) from the prior filing, attributed to a convertible bond conversion price adjustment and open-market buying and/or selling by a specially related party (특별관계자).
- No voting agreement or joint exercise of control (공동보유) figures were disclosed; the controlling stake fields are marked as not applicable.
View original DART filing ↗highspotted 17:22 KST
Hans Biomedical (KRX: 042520)- Osstem Implant (오스템임플란트), reported as major shareholder, now holds 1,415,354 shares representing 12.48% of Hans Biomedical
- Previous IRDS (convertible instrument) position was 58,373 shares or 0.44% of total
- Stake increase triggered by conversion price adjustment and related-party on-market purchases/sales
View original DART filing ↗highspotted 15:40 KST
Hans Biomedical (KRX: 042520)- Ostem Implant increased holding in Hans Biomedical to 1,415,354 shares representing 12.48% of outstanding stock as of 4 April 2025
- Change driven by conversion price adjustment and on-market purchases/sales by related parties
- Separately, 58,373 shares (0.44%) held in treasury stock account
View original DART filing ↗AI-generated summaries of public DART filings. May contain errors — always verify against the original (linked). Not investment advice.